bicalutamide has been researched along with Triple Negative Breast Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Grellety, T | 1 |
| Kong, Y; Qu, F; Yan, X; Yu, W; Yuan, X | 1 |
| Abdelhamid, MI; Abdelrahman, AE; Alnagar, AA; Elwan, A; Nawar, N | 1 |
| Auricchio, F; Castoria, G; Di Donato, M; Giovannelli, P; Migliaccio, A | 1 |
| Bevan, CL; Brooke, GN; Fioretti, FM; Sita-Lumsden, A | 1 |
| Cuenca-López, MD; Montero, JC; Morales, JC; Ocana, A; Pandiella, A; Prat, A | 1 |
| Guan, X; Li, Y; Song, W; Xu, Y; Yang, F; Yin, Y; Zhang, W; Zhu, A | 1 |
| Guan, X; Jin, J; Luo, J; Shi, Y; Sun, Z; Xu, J; Yang, F; Zhang, W | 1 |
2 review(s) available for bicalutamide and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
[Androgen receptor-positive triple negative breast cancer: From biology to therapy].
Topics: Abiraterone Acetate; Age Factors; Aged; Androgen Antagonists; Anilides; Benzamides; Class I Phosphatidylinositol 3-Kinases; Clinical Trials as Topic; Drug Screening Assays, Antitumor; Female; Forecasting; Humans; Mutation; Nitriles; Phenylthiohydantoin; Prognosis; Rare Diseases; Receptors, Androgen; Signal Transduction; Tosyl Compounds; Triple Negative Breast Neoplasms | 2020 |
Revising the role of the androgen receptor in breast cancer.
Topics: Abiraterone Acetate; Androgen Antagonists; Androgens; Androstadienes; Anilides; Estrogen Antagonists; Female; Humans; Nitriles; Receptors, Androgen; Receptors, Estrogen; Signal Transduction; Steroid 17-alpha-Hydroxylase; Tamoxifen; Tosyl Compounds; Triple Negative Breast Neoplasms | 2014 |
6 other study(ies) available for bicalutamide and Triple Negative Breast Neoplasms
| Article | Year |
|---|---|
Effect of Bicalutamide on the proliferation and invasion of human triple negative breast cancer MDA-MB-231 cells.
Topics: Adult; Anilides; Cell Proliferation; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Nitriles; Tetrazolium Salts; Tosyl Compounds; Triple Negative Breast Neoplasms | 2020 |
Clinicopathological Features and Treatment Challenges in Triple Negative Breast Cancer Patients: A Retrospective Cohort Study.
Topics: Administration, Metronomic; Adult; Aged; Androgen Antagonists; Anilides; Antineoplastic Agents; Biomarkers, Tumor; Capecitabine; Chemotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Female; Humans; Middle Aged; Nitriles; Retrospective Studies; Risk Factors; Time Factors; Tosyl Compounds; Triple Negative Breast Neoplasms; Young Adult | 2021 |
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly.
Topics: Androgens; Anilides; Cell Line, Tumor; Cell Movement; Female; Focal Adhesion Kinase 1; Gene Knockdown Techniques; Humans; MCF-7 Cells; Multiprotein Complexes; Neoplasm Invasiveness; Nitriles; Phosphatidylinositol 3-Kinases; Receptors, Androgen; src-Family Kinases; Tosyl Compounds; Triple Negative Breast Neoplasms | 2019 |
Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling.
Topics: Anilides; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Molecular Targeted Therapy; Nitriles; Receptors, Androgen; TOR Serine-Threonine Kinases; Tosyl Compounds; Triple Negative Breast Neoplasms | 2014 |
Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer.
Topics: Anilides; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Dihydrotestosterone; Female; Gene Expression Regulation; Humans; Mice; Neoplasm Transplantation; Nitriles; Receptors, Androgen; Tosyl Compounds; Triple Negative Breast Neoplasms; Tumor Protein p73 | 2016 |
The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer.
Topics: Anilides; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzimidazoles; Blotting, Western; BRCA1 Protein; Cell Line; Cell Line, Tumor; Cell Survival; Female; Flow Cytometry; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Poly (ADP-Ribose) Polymerase-1; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Tosyl Compounds; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2016 |